Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    22547592 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
Conditions: Limited Stage Small Cell Lung Cancer;   Small Cell Lung Cancer
Interventions: Drug: Ipilimumab;   Drug: Nivolumab
2 Recruiting Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Topotecan;   Drug: Pembrolizumab
3 Recruiting Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: MK-3475;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed
4 Recruiting Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab

Study has passed its completion date and status has not been verified in more than two years.